SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (15319)2/19/1998 12:00:00 PM
From: Flagrante Delictu  Respond to of 32384
 
Henry, This info on the effect of HDAC1 on acute promyelocytic leukemia should enable LGND to become the dominant player in that market. The scientific knowledge gained should prove applicable across other indications. Bernie.



To: Henry Niman who wrote (15319)2/27/1998 2:33:00 PM
From: Flagrante Delictu  Respond to of 32384
 
Henry, Thanks very much for enabling us to access all the related papers. They certainly enable an understanding of the exciting science that should enable LGND to reach its manifest destiny. Bernie


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News